Abstract: Inflammatory bowel diseases are characterized by a chronic clinical course of relapse and remission associated with self-destructive inflammation of the gastrointestinal tract. Active extracts from plants have emerged as natural potential candidates for its treatment. Abarema cochliacarpos (Gomes) Barneby & Grimes, Fabaceae (Barbatimão), is a native medicinal plant in to Brazil. Previously we have demonstrated in an acute colitis model a marked protective effect of a butanolic extract, so we decided to assess its anti-inflammatory effect in a chronic ulcerative colitis model induced by trinitrobenzensulfonic acid (TNBS). Abarema cochliacarpos (150 mg/day, v.o.) was administered for fourteen consecutive days. This treatment decreased significantly macroscopic damage as compared with TNBS. Histological analysis showed that the extract improved the microscopic structure. Myeloperoxidase activity (MPO) was significantly decreased. Study of cytokines showed that TNF-α was diminished and IL-10 level was increased after Abarema cochliacarpos treatment. In order to elucidate inflammatory mechanisms, expression of cyclooxygenase (COX)-2 and nitric oxide synthase (iNOS) were studied showing a significant downregulation. In addition, there was reduction in the JNK and p-38 activation. Finally, IκB degradation was blocked by Abarema cochliacarpos treatment being consistent with an up-regulation of the NF-kappaBbinding activity. These results reinforce the anti-inflammatory effects described previously suggesting that Abarema cochliacarpos could provide a source for the search for new anti-inflammatory compounds useful in ulcerative colitis treatment.
Introduction
Inflammatory bowel diseases (IBD) such as Crohn's disease (CD) and ulcerative colitis (UC) are illness characterized by a chronic clinical course of relapse and remission associated with self-destructive inflammation of the gastrointestinal tract. IBD has long been appreciated to have a genetic basis and likely involves a response of the immune system to some environmental agent(s). What differentiates the inflammatory responses observed in IBD from normal gut is an inability to downregulate these responses (Gambero et al., 2007; Kaser et al., 2010) . One of the earliest factors involved is the breach of the intestinal epithelial barrier and the development of abnormal immune and inflammatory responses that are mediated predominantly by activated neutrophils, monocytes, lymphocytes, and macrophages (Schmidt & Stallmach, 2005; Thompson-Chagoyan et al., 2005) . Infiltrated granulocytes and macrophages produce high levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), that plays a central role in mucosal inflammation and is likely to be at the apex of the inflammatory cascade in IBD (Waetzig et al., 2002; Talero et al., 2008) . Another mediators that have been closely associated with the initiation and maintenance of intestinal inflammation are COX-2 and iNOS, which play a pivotal role in mediating inflammation; both produce important inflammatory mediators that contribute to loss the integrity of the colonic mucosal (Sánchez-Calvo et al., 2009; Sánchez-Fidalgo et al, 2010) .
Among the signaling pathways which are involved in the development or propagation of IBD, § The fi rst two authors contributed equally.
Chronic administration of Abarema cochliacarpos attenuates colonic
inflammation in rats Maria Silene da Silva et al. the mitogen-activated protein kinases (MAPK) and/ or the nuclear factor ĸB (NF-ĸB) are of particular interest (Atreya et al., 2008) , by modulating a number of different steps in the inflammatory cascade. Recent studies have highlighted the importance of the MAPK pathway, moreover it has been shown that specific inhibitors against p38 and JNK attenuate the disease (Kwon et al., 2007; Di Mari et al., 2007; Hollenbach et al., 2005; Assi et al., 2006; Broom et al., 2009 ). On the other hand, NF-κB dimers are kept in an inactive cytoplasmic complex by inhibitory proteins, the inhibitor protein kappa B (IκB) family, in resting cells. Phosphorylation of IκB generally leads to the rapid dissociation of the complex accompanied by proteolytic degradation of IκB and release of NF-κB that subsequently transmigrate from cytoplasm into the nucleus. NF-κB can induce gene transcription by binding to specific promoter elements (Atreya el al, 2008; Glasgow et al, 2000; Tak & Firestein, 2001) .
Abarema cochliacarpos (Gomes) Barneby & Grimes, Fabaceae, is an ornamental tree and native medicinal species in to Brazil. It is popularly known as "barbatimão" or "babatenã". It appears mainly in the Atlantic Forest and in the Caatinga (dryland) region of Northeastern Brazil, which hosts many different ethnic communities (Albuquerque et al., 2007; World Conservation Center, 1998) . In this same region, on the traditional medicine of Colônia Treze village (Lagarto/ Sergipe) the decoction of stem bark of Abarema cochliacarpos is frequently used for wound-healing, as an analgesic and anti-inflammatory (Silva et al., 2006; Silva et al., 2009) .
Previous studies performed by our group have shown the antiulcer effect of the aqueous extract of the bark in experimental alcohol gastric ulcer demonstrating for the first time a reduction of the lesions (Silva et al., 2006) . Recently, the butanolic fraction of the methanolic extract was tested on acute experimental colitis model induced by trinitrobenzene sulfonic acid (TNBS) and showed anti-inflammatory effects. Moreover, phytochemical screening of this fraction by electrospray ionization (ESI)/MS was also performed showing a high content of polyphenols. Its major constituents were catechins, flavonoid-type compounds and the minor were its dimers and trimers. The tannins belong to the proanthocyanidin subgroup. The NMR characterization shown the major constituent was (+)-catechins (da Silva et al., 2010) .
Ethnopharmacological studies demonstrated that Abarema cochliacarpos is used in traditional medicine for many diseases, including gastrointestinal diseases, through the daily ingestion of this decoction or the tincture, which is made by placing the bark in white wine or "cachaça" (Silva et al., 2006; Santos, 2008) . Thus, considering this fact, and the promising results that have been showed by acute administration of butanolic fraction of Abarema cochliacarpos, we decided to assess the response and mechanisms involved after its chronic administration in experimental colitis induced by TNBS.
We evaluated the inflammatory response by histological analysis and by the determination of inflammation markers such as MPO activity and cytokines profile. In order to gain a better insight into the action mechanism(s) the expression of inducible enzymes COX-2 and iNOS, the expression and activation of MAPKs and IκB degradations were also analyzed by Western blotting.
Materials and Methods

Plant material
The bark of Abarema cochliacarpos (Gomes) Barneby & Grimes, Fabaceae, was obtained from collection by Maria Silene da Silva and the folk medicine practitioner, in Colônia Treze village, Lagarto city, Sergipe state, Brazil, in July 2006. Voucher specimens of this species were identified by Prof. Dra. Christine Niezgoda from Field Museum of Natural History and was deposited under number 007628 at the Federal University of Sergipe.
Preparation of the extract
Fresh bark of Abarema cochliacarpos was dried at room temperature for 10-14 days. Then it was powdered (1200 g) and exhaustively extracted with methanol (5 L) at room temperature during fifteen days at room temperature by maceration. The suspension was concentrated at 40 °C under reduced pressure to provide a crude metanolic extract with 34.61% yield (415.4 g).
The methanolic extract (200 g) was partitioned three times with a mixture of ethyl acetate: water (1:1, v/v). The ethyl acetate fraction was evaporated at 35 °C under reduced pressure to obtain an ethyl acetate fraction (AF) of 46.12 g (23.06% yield). The aqueous phase was partitioned with a mixture of n-butanol/ water (1:1 v/v, three times), producing 92.62 g of butanolic fraction (AC) with 46.31% yield and 45.19 g of aqueous fraction (AQF) with 22.59% yield.
Animals
Male and female Wistar rats supplied by Animal Services of the University of Seville, Spain, weighing 180-200 g, were placed in singled in cages with wire-net floors in a controlled room (temperature 24-25 °C, humidity 70-75%, lighting regimen of 12L/12D) and were fed a normal Chronic administration of Abarema cochliacarpos attenuates colonic inflammation in rats Maria Silene da Silva et al. laboratory diet (Panlab, Barcelona, Spain) . Rats were deprived of food for 12 h prior to the induction of colitis, but were allowed free access to tap water throughout. They were randomly assigned to groups of 8-13 animals. Experiments followed a protocol observed by the Animal Ethics Committee of the University of Seville and all experiments were in accordance with the recommendations of the European Union regarding animal experimentation (Directive of the European Counsel 86/609/EC).
Induction of colitis
Colitis was induced according to the procedure described by Morris et al. (1989) . Briefly, rats were slightly anesthetized with 12% chloral hydrate by intraperitoneal route (i.p.) following a 12 h fast, and then a medical-grade polyurethane cannula for enteral feeding (external diameter 2 mm) was inserted into the anus and the tip was advanced to 8 cm proximal to the anus verge. TNBS (Sigma-Chemical Co., St. Louis, MO, USA) dissolved in ethanol (50%, v/v) was instilled into the colon through the cannula (TNBS-30 mg in a volume of 0.25 mL to induce a long-chronic colitis) and the animals were maintained in a headdown position for a few minutes (2-3 min) to prevent leakage of the intracolonic instillate.
Butanolic fraction of Abarema cochliacarpos (150 mg/kg) was suspended in 2% Tween 80 (SigmaChemical Co., St. Louis, MO, USA) (Santos el al, 2004) and was administered in a volume of 10 mL/kg body weight by oral route 24 h after TNBS instillation and, daily during the two weeks before the sacrifice. We selected this dose of the extract since this was the most active in acute study (da Silva et al, 2010) . A reference control group was applied for comparison with the TNBS colon instillation group: the sham group that received physiological saline instead of the TNBS solution in a comparable volume. Sham and TNBS groups also received the vehicle by oral route. The rats were checked daily for behavior, body weight, and stool consistency.
Assessment of colitis
An independent observer who was blinded to the treatment evaluated the severity of colitis. For each animal, the distal 10 cm portion of the colon was removed and cut longitudinally, slightly cleaned in physiological saline to remove fecal residues and weighed. Macroscopic damage was quantified measuring the extent of the lesions in the distal colon (mm 2 ) using Bioview 4 (AvSoft, Brazil) an image analysis software (Khan, 2004) . The presences of adhesions (score 0-2), and/or stool consistency (score 0-1) were evaluated according to the criteria of BobinDubigeon et al. (2001) with slight modifications. Photographs taken from colon samples were digitized using Kodak D290 Zoom camera (Eastman Kodak Co., Rochester, NY, USA). Pieces of colon were collected and frozen in liquid nitrogen for measurement of biochemical parameters.
Histological studies
For examination with the light microscope we used tissue samples from the distal inflamed colon of each animal and fixed in 4% buffered formaldehyde, then submerged into 20-30% sucrose and after embebed in tissue freezing medium (Tissue-Tek Sakura, Netherlands), and finally were frozen in liquid nitrogen. 7 µm thick slices were obtained by utilizing a cryostat (HM 525, Microm, Walldorf, Germany) and stored at -80 °C until use. The samples were stained with hematoxylin-eosin in accordance with the standard procedures for histological evaluation of colonic damage. All tissue sections were examined in an Olympus BH-2 microscope (GMI, MN, USA). Motic Images 2000 software was used for characterization of histopathological changes.
Assessment of leukocyte involvement
Myeloperoxidase (MPO) activity, an indicator of polymorphonuclear leukocyte accumulation, was assessed de according to the method of Bradley et al. (1982) with slight modifications. Samples were obtained from all animals were weighed and homogenized in 10 volumes of 50 mM potassium phosphate buffer (PBS), pH 7.4. The homogenates were centrifuged at 20,000g, 20 min, 4 °C. The pellets were again homogenized in 10 volumes PBS, pH 6.0, containing 0.5% hexadecyltrimethylammonium bromide (HETAB) and 10 mM ethylenediaminetetraacetic acid (EDTA). These homogenates were subjected to one cycle of freezing/ thawing and a brief period of sonication.
The supernatants (50 µL) were diluted in 10 volumes of 50 mM PBS, pH 6. Then it was added consecutively 50 µL of O-dianisidine dihydrochloride (0.067%), of HETAB (0.5%) and of hydrogen peroxide (0.003%). Each well containing the complete reaction mixture was incubated for 5 min. The changes in absorbance at 450 nm were measured with a microplate reader (Labsystem Multiskan EX, Helsinki, Finland). One unit MPO activity was defined as the amount of enzyme present that produced a change in absorbance of 1.0 U/min in the final reaction volume.
Assessment of TNF-α and IL-10
* Chronic administration of Abarema cochliacarpos attenuates colonic inflammation in rats Maria Silene da Silva et al. Distal colon samples were weighed and homogenized, after thawing, in ten volumes PBS, pH 7.2, 1% bovine serum albumin (BSA) at 4 °C. They were centrifuged at 12,00 x g for 10 min and the supernatants were collected and stored at -80 °C. Mucosal cytokines levels were assayed with quantitative TNF-α (eBioscience, San Diego,CA ) and IL-10 (Diaclone, Besançon,France) enzyme immunoassay kits. TNF-α and IL-10 values were expressed as pg/mg tissue.
Western blotting assay
Frozen colonic tissues were weighed and homogenized in ice cold buffer (50 mM Tris-HCl, pH 7.5, 8mM MgCl 2 , 5mM ethylene glycol bis (2-aminoethyl ether)-N,N,N'N'-tetraacetic acid (EGTA), 0.5 mM EDTA, 0.01 mg/mL leupeptin, 0.01 mg/mL pepstatin, 0.01 mg/mL aprotinin, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 250 mM NaCl. Homogenates were centrifuged (12000 x g, 15min, 4 °C) and the supernatants were collected and stored at -80 °C. Protein concentration of the homogenate was determined following Bradford's colorimetric method. Aliquots of supernatants containing equal amounts of protein (50 µg) were separated on 10% acrylamide gel by sodium dodecyl sulfate polyacryamide gel electrophoresis. In the next step, the proteins were electrophoretically transferred onto a nitrocellulose membrane and incubated with specific primary antibodies: rabbit polyclonal anti-COX-2 and antiiNOS (Cayman Chemical, USA) at dilution of 1:3000, mouse polyclonal anti-JNK and anti-pJNK (Cell Signalling Technology, USA) at dilution of 1:2000 and 1:500 respectively, and mouse polyclonal anti-p38 and anti-p-p38 (Santa Cruz Biotecnology, Inc) at dilution of 1:1000 overnight at 4 ºC. After, each filter was washed three times for 15 min and incubated with the anti-rabbit (Pierce Biotechnology, IL, U.S.A) and antimouse (Sigma-Aldrich, MO, USA) immunoglobulin G antibodies respectively. To prove equal loading, the blots were analyzed for β-actin expression using an anti-β-actin antibody (Sigma-Aldrich, MO, USA). Immunodetection was performed using enhanced chemiluminiscence light-detecting kit (SuperSignal ® West Femto Chemiluminescent Substrate, Pierce, IL, USA). Densitometric data were studied following normalization to the control (housekeeping gene). The signals were analyzed and quantified by a Scientific Imaging Systems (KODAK 1D, Image Analysis Software).
IκBα degradations analysis
Using the western blot technique as herein before narrated for cytoplasmic protein extracts, it was evaluated degradations of cytoplasmic IκB protein of intestinal mucosa. The specific primary antibody used was rabbit polyclonal anti-IκBα (Cell Signalling Technology, USA) at dilution of 1:1000 and the next day with the anti-rabbit immunoglobulin G antibodies (Pierce Biotechnology, IL, USA).
Statistic analysis
All values in the figures and text are expressed as arithmetic means±standard error of the mean (SEM). Data were evaluated with Graph Pad Prism1 Version 5 software. The statistical significance of any difference in each parameter among the groups was evaluated by one-way analysis of variance (ANOVA) followed by Tukey test. p values of <0.05 were considered statistically significant. In the experiment involving histology, the figures shown are representative of at least three experiments performed on different days.
Results
At
fourteen days after intracolonic administration of TNBS, control animals underwent severe anorexia with a marked body weight loss and intense diarrhea in the majority of animals in comparison with sham group (p<0.001). Presence of adhesions to adjacent organs and a marked increase in the weight/length of the colon were also observed in TNBS treated rats (p<0.001) ( Table 1) . Macroscopic inspection of the colon after two weeks of colitis induction showed a flaccid appearance, bowel wall thickening, inflammation and ulcers. The damage was Regarding the pro-inflammatory cytokines production, the colonic injury provoked by 30 mg of TNBS administration by animal was characterized by a significant increase in TNF-α levels (40.95±5.45 pg/ mg tissue, p<0.01 vs. sham group). After treatment with Abarema cochliacarpos, data clearly indicated a significant reduction in this cytokine (18.94±0.44 pg/ mg tissue, p<0.01, vs. TNBS group) ( Figure 1C) .
In contrast, IL-10 levels were diminished in TNBS control group (2.05±0.71 pg/mg tissue, p<0.05 vs. sham group) and Abarema cochliacarpos administration increased IL-10 levels, reaching values similar to sham group (6.63±0.70 pg/ mg tissue, p<0.01 vs. TNBS group) ( Figure 1D ).
The levels of expression of COX-2 and iNOS were measured by western blotting of cytosolic extracts from colonic mucosa. Exposure of colon to TNBS caused strong expression of COX-2 and iNOS (p<0.001 and p<0.01 respectively), indicating that these proteins expression could be induced at the chronic stage of colonic lesion caused by TNBS. Nevertheless, oral administration of Abarema cochliacarpos was able to diminish significantly the up-regulation of both COX-2 quantified and the affected area was 1169±116.30 mm 2 (p<0.001) ( Figure 1A and Figure 2B ).
After Abarema cochliacarpos treatment in TNBS-rats during 14 days, significant changes were observed respect to the presence of diarrhea (p<0.05), adhesions to adjacent organs (p<0.05) and colon weight/ length (p<0.01) vs. TNBS control group; although no significant reduction in the body weight loss was observed. Treatment with Abarema cochliacarpos also significantly ameliorated the extent and severity of the colonic inflammation, reflecting signs of greater recovery as evidenced by the quantification of macroscopic damage (291.8±10.82 mm 2 ; p<0.001 vs. TNBS group) as is reflect in Figure 1A and Figure 2C .
The histological analysis of the colon of sham-treated rats showed typical features of normal structure ( Figure 2D ). In TNBS-treated rats, the inflammation extended through the mucosa and submucosa. Extensive granulation tissue with presence of fibroblasts and lymphocytes, leukocytes, and diffuse inflammatory infiltrates was apparent ( Figure 2E ). The mucosa adjacent to lesions showed extensive crypt distortion and goblet cells were totally absent at the surface epithelium. After chronic administration of Abarema cochliacarpos, the colonic histopathology was dramatically reduced: there was an attenuation of morphological signs of cell damage; the colonic mucosa showed ulcers in the process of healing, goblet cells were most visible and a repair process was observed in some areas. The mucosa showed a healing course with signs of mucosal reepithelization ( Figure 2F, 2G) .
As shown in Figure 1B , the colitis caused by Chronic administration of Abarema cochliacarpos attenuates colonic inflammation in rats Maria Silene da Silva et al. and iNOS proteins (p<0.05, vs TNBS) ( Figure 3A , 3B).
JNK and p38 MAPK protein activation was also detected in cytosolic extracts of normal colon mucosa by western blot using phosphospecific MAPK antibodies (Figure 4) . To standardize protein loading in each line, blots were stripped and re-probed with the corresponding antibodies against both proteins. Phosphorylation of JNK protein was not detected in cytosolic extracts of normal colon mucosa, whereas a high expression appeared in colon mucosa from control TNBS-treated rats (p<0.01 vs. sham group), indicating that JNK protein activation could be induced at the chronic stage of colonic lesion caused by TNBS. Nonetheless, upon treatment with Abarema cochliacarpos the protein expression of p-JNK was significantly decreased (p<0.05 vs TNBS group) ( Figure  4A ). Study from p38 protein showed that it remained unchanged in all groups, indicating that this protein was constitutively expressed in the colonic tissue and, its activation was significantly changed after TNBS-enema (p<0.001 vs. sham group). Chronic Abarema cochliacarpos administration demonstrated a significantly reduction of phosphorylation of this protein (p<0.05 vs TNBS group) ( Figure 4B ).
Since NF-κB activity is controlled by the steady state level of IκBα we further investigated the effect of Abarema cochliacarpos on IκB degradation in rat's colonic mucosa. As shown in Figure 5 , protein extracts of colon tissues showed that intestinal inflammation of TNBS group induced a significant IκB degradation which is consistent with an up-regulation of the NFkappaB-binding activity. However, this was blocked by Abarema cochliacarpos treatment.
Discussion
In particular we have demonstrated that fourteen days of Abarema cochliacarpos treatment decreased the degree of adhesions, diarrhea and colon weight/length, as well as colonic macroscopic damage. There was an attenuation of morphological signs of cell damage, the colonic mucosa showed ulcers at the beginning of Chronic administration of Abarema cochliacarpos attenuates colonic inflammation in rats Maria Silene da Silva et al. reepithelization and healing process. The infiltration of polymorphonuclears and the increase on TNF-α production caused by TNBS in the colon were also diminished after Abarema cochliacarpos treatment. Moreover, administration of the extract was able to increase the levels of the anti-inflammatory cytokine IL-10, which were diminished after TNBS administration. COX-2 and iNOS proteins were downregulated after administration of Abarema cochliacarpos as well as the intestinal phosphorylation of JNK and p38. Moreover, this extract blocked IκB degradation.
As we have mentioned above phytochemical screening results from butanolic fraction of Abarema cochliacarpos demonstrated that its main bioactive constituents is (+)-catechin (da Silva et al, 2010) . Several studies have demonstrated that catechins intake has been associated with a wide whose variety of beneficial health effects in vitro, in vivo and clinically, including experimental model of ulcerative colitis (Sato et al, 1998; Mazzon et al, 2005) , although its mechanism of action is unknown yet.
Studies of bioavailability of catechins show that although most of an oral dose of catechins remains in the gut and becomes available for metabolism by the colonic microflora, some certainly are absorbed and appear in the plasma (Gee & Johnson, 2001; Nakagawa & Miyazawa, 1997) . Conversely, Okushio et al. (1996) confirmed that the principal catechins of green tea are absorbed in the rat small intestine by measuring their appearance in the Chronic administration of Abarema cochliacarpos attenuates colonic inflammation in rats Maria Silene da Silva et al. portal circulation after an oral dose. All these observations may have significance on the beneficial effect of Abarema cochliacarpos in our ulcerative chronic colitis model.
Whatever the trigger of IBD, neutrophils are early responders and play a central role in the inflammatory process. During the initial innate immune response, they are seen passing from the circulation through gaps in the vascular endothelium to infiltrate the tissues (Villegas et al., 2003) . Once there, neutrophils release antimicrobial peptides, as enzyme MPO, which catalyses the formation of such potent cytotoxic oxidants as hypochlorous acid from hydrogen peroxide and chloride ions and N-chloramines (Martin et al., 2006) and reactive oxygen intermediates that may in themselves cause further tissue damage (Hanauer, 2006) .The increase in MPO activity in TNBStreated animals was reduced after chronic administration of Abarema cochliacarpos. Microscopic evaluation also revealed an increased number of neutrophil leukocytes that possibly contributed to the elevated MPO activity observed in TNBS group. This anti-inflammatory effect has already been demonstrated after acute treatment (da Silva et al., 2010 ), but we confirm these previous results and demonstrate that this effect has been higher after chronic treatment. The antioxidant activity of phenol compounds, as well as catechins, has been shown by many studies. In this way, the reduction in colonic MPO activity as well as the reduction of cellular infiltration after treatment with Abarema cochliacarpos may be reflective of its antioxidant and anti-inflammatory effects.
Some works by our group have shown that in this well-characterized TNBS-induced colitis model mucosal pro-inflammatory cytokines increase, such as IL-1β, IL-6 and TNF-α, induces the production of chemoattractants for neutrophils, which regulate endothelial adhesion molecules expression on vascular endothelial cells and promote neutrophil adherence to these cells Camacho-Barquero et al., 2007; Talero et al., 2008; Sánchez-Calvo et al., 2009 ). On the other hand, the cytokine IL-10 inhibits both antigen presentation and subsequent release of pro-inflammatory cytokines, thereby attenuating mucosal inflammation in IBD (Sanchez-Muñoz et al., 2008) . This anti-inflammatory cytokine possesses important immune-modulatory properties and its deficiency allows for the development of unrestrained activation of a Th-1-mediated immune response (Wirtz & Neurath, 2007) , as it occurs in the spontaneous colitis induced in IL-10-knockout mice (Strober et al., 2002) . Therefore, it has been suggested that using different strategies that increase IL-10 may be useful in IBD therapy.
The present results show that chronic administration of Abarema cochliacarpos was able to diminish TNF-α levels and significantly to increase IL-10 levels. These results are of interest since although the diminution of TNF-α levels after Abarema cochliacarpos administration has been observed in the acute colitis model (da Silva et al., 2010) , the increase of the antiinflammatory IL-10 cytokine after chronic treatment has not been demonstrated yet. Thus, chronic administration of (+) catechins from Abarema cochliacarpos seems capable to modulate the Th1/Th2 response, which may be other of the mechanisms of action responsible to the improvement of the colitis. Previous studies have shown as epicatechins from green tea extracts exhibit similar effects, they decreased TNF-α in others IBD models (Mazzon et al., 2005; Ran et al., 2008; Varilek et al., 2001 ) and stimulated IL-10 production in human leukocytes (Crouvesier et al., 2001) .
Macroscopic damage in this chronic colitis model was associated with both COX-2 and iNOS overexpression and, (+)-catechins from Abarema cochliacarpos fraction significantly down regulated both proteins. Many researchers show the effects of catechins on COX-2 and iNOS activities in different in vivo and in vitro studies (Seeram et al., 2003; Peng et al., 2006; Chan et al., 1997; Shirakami, et al., 2008; Ran et al., 2008) , demonstrating its involvement on COX-2 and iNOS expression. Therefore, these findings are significant since it has been shown as inhibition of both proteins by Abarema cochliacarpos administration improves chronic inflammation in this disease. Chronic administration of Abarema cochliacarpos attenuates colonic inflammation in rats Maria Silene da Silva et al. In order to deep in the mechanism of action, MAPKs and NFκB activation were studied. MAPKs have been implicated in many physiologic processes, including cell proliferation, differentiation, and death. The three major types of MAPKs in mammalian cells are ERK, the p38 MAPKs, and JNK, which support a role in mediating IBD (Broom et al., 2009) . In this study, we showed that activation of JNK and p38 by TNBS was downregulated by (+)-catechins from Abarema cochliacarpos, which is of interesting because inflammatory responses -mainly cytokine production, inflammatory cell infiltration and COX-2 and iNOS upregulation-have been shown to be attenuated by usage of specific inhibitors against JNK and p38 MAPKs (Kwon et al., 2007; Hayashi, 2000; Di Mari et al., 2007; Hollenbach et al., 2005; Assi et al., 2006; Broom et al., 2009 ). On the other hand, NFκB could be an important molecular target and its activation has been linked to inflammation. Phosphorylation of IκB generally leads to the degradation of IκBα, with the concomitant release of NFκB and nuclear translocation of NFκB, which binds to the promoter of many pro-inflammatory genes, most notably iNOS, COX-2, and TNF among others (Cheung & Kong 2010) . We have demonstrated that the extract of Abarema cochliacarpos was able to block the degradation of IκBα.
Recently, catechins have been shown to inhibit the MAPK pathway and NF-κB activity (Kim et al., 2009; Guiterrez-Orozco et al., 2010) . Consistent with these reports, our findings suggest that the inhibition of MAPK activation and NF-κB activity might be a good therapeutic strategy for TNBS-induced ulcerative colitis and propose that the inhibitory effect of catechins from Abarema cochliacarpos on inflammatory mediator expression could be mediated, at least in part, by blocking the MAPK pathway with subsequent inhibition of NF-κB activity.
In conclusion, this study demonstrates that the degree of colitis caused by administration of TNBS is significantly attenuated by (+) catechin, the major constituent of Abarema cochliacarpos. The antiinflammatory effects are associated with (i) a reduction in pro-inflammatory T-helper 1 cytokine response, (ii) an increase in anti-inflammatory T-helper 2 cytokine response leading to the attenuation of the recruitment of neutrophils, (iii) attenuation of COX-2 and iNOS proteins expression potentially by modulation of MAPK pathway and inhibition of NF-κB activity. In conclusion, these results reinforce the anti-inflammatory effects described previously, suggesting that Abarema cochliacarpos could provide a source for the search for new anti-inflammatory compounds useful in ulcerative colitis treatment
